Gemmer Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Gemmer Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-189	Closed	-$7K	–	1257
2016 Q3	$7K	Hold	189	–	–	﹤0.01%	791
2016 Q2	$3K	Hold	189	–	–	﹤0.01%	1100
2016 Q1	$3K	Hold	189	–	–	﹤0.01%	1002
2015 Q4	$7K	Buy	189 +128	+210%	+$8.26K	﹤0.01%	727
2015 Q3	$6K	Hold	61	–	–	﹤0.01%	775
2015 Q2	$5K	Buy	+61	New	+$5.22K	﹤0.01%	880

Other funds holding CLVS

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return